Loading…

The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor

The COVID-19 disease has plagued over 200 countries with over three million cases and has resulted in over 200,000 deaths within 3 months. To gain insight into the high infection rate of the SARS-CoV-2 virus, we compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein...

Full description

Saved in:
Bibliographic Details
Published in:Viruses 2020-04, Vol.12 (5), p.497
Main Authors: Brielle, Esther S, Schneidman-Duhovny, Dina, Linial, Michal
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983
cites cdi_FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983
container_end_page
container_issue 5
container_start_page 497
container_title Viruses
container_volume 12
creator Brielle, Esther S
Schneidman-Duhovny, Dina
Linial, Michal
description The COVID-19 disease has plagued over 200 countries with over three million cases and has resulted in over 200,000 deaths within 3 months. To gain insight into the high infection rate of the SARS-CoV-2 virus, we compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations. SARS-CoV, SARS-CoV-2, and HCoV-NL63 recognize ACE2 as the natural receptor but present a distinct binding interface to ACE2 and a different network of residue-residue contacts. SARS-CoV and SARS-CoV-2 have comparable binding affinities achieved by balancing energetics and dynamics. The SARS-CoV-2-ACE2 complex contains a higher number of contacts, a larger interface area, and decreased interface residue fluctuations relative to the SARS-CoV-ACE2 complex. These findings expose an exceptional evolutionary exploration exerted by coronaviruses toward host recognition. We postulate that the versatility of cell receptor binding strategies has immediate implications for therapeutic strategies.
doi_str_mv 10.3390/v12050497
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cbca5c9cef194d53899641b7cb9da9aa</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cbca5c9cef194d53899641b7cb9da9aa</doaj_id><sourcerecordid>2398025812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhi0EoqVw4A8gS1zgsODPXc8FKQqBRqqE1BYkTpbX600cbdap7Q3032OaErWcPPI8ejQzL0KvKfnAOZCPe8qIJAKaJ-iUAkAlgMqnD-oT9CKlDSF1DaR5jk4447VsJD1FP6_XDl_NLq-qefhRMbz47WJO2ODPPmU_2uz3pZ-jyW51i_sQ8XLMLprSGFf4l89rnIthNl8wfD5tzYgvnXW7HOJL9Kw3Q3Kv7t8z9P3L4np-Xl18-7qczy4qK2rIlRKdkq1yyjLLW9ZKUMw1itbC9haoAku56CnUktNWkoZ3ljFDWqMo6zpQ_AwtD94umI3eRb818VYH4_XdR4grbWL2dnDattZIC9YVn-gkVwC1oG1jW-gMGFNcnw6u3dRuXWfdWDYfHkkfd0a_1quw1w0DSiQvgnf3ghhuJpey3vpk3TCY0YUpacZB1aJcnxb07X_oJkxxLKe6owiTZcNCvT9QNoaUouuPw1Ci_4avj-EX9s3D6Y_kv7T5H_sQp-c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398025812</pqid></control><display><type>article</type><title>The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Coronavirus Research Database</source><creator>Brielle, Esther S ; Schneidman-Duhovny, Dina ; Linial, Michal</creator><creatorcontrib>Brielle, Esther S ; Schneidman-Duhovny, Dina ; Linial, Michal</creatorcontrib><description>The COVID-19 disease has plagued over 200 countries with over three million cases and has resulted in over 200,000 deaths within 3 months. To gain insight into the high infection rate of the SARS-CoV-2 virus, we compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations. SARS-CoV, SARS-CoV-2, and HCoV-NL63 recognize ACE2 as the natural receptor but present a distinct binding interface to ACE2 and a different network of residue-residue contacts. SARS-CoV and SARS-CoV-2 have comparable binding affinities achieved by balancing energetics and dynamics. The SARS-CoV-2-ACE2 complex contains a higher number of contacts, a larger interface area, and decreased interface residue fluctuations relative to the SARS-CoV-ACE2 complex. These findings expose an exceptional evolutionary exploration exerted by coronaviruses toward host recognition. We postulate that the versatility of cell receptor binding strategies has immediate implications for therapeutic strategies.</description><identifier>ISSN: 1999-4915</identifier><identifier>EISSN: 1999-4915</identifier><identifier>DOI: 10.3390/v12050497</identifier><identifier>PMID: 32365751</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>ACE2 ; Angiotensin-Converting Enzyme 2 ; Atoms &amp; subatomic particles ; Betacoronavirus - chemistry ; Betacoronavirus - metabolism ; Binding sites ; Coronaviridae ; coronavirus evolution ; Coronavirus NL63, Human - chemistry ; Coronavirus NL63, Human - metabolism ; Coronaviruses ; COVID-19 ; Disease transmission ; Epidemics ; Exploration ; Humans ; Interfaces ; Middle East respiratory syndrome ; molecular dynamics ; Molecular Dynamics Simulation ; Peptidyl-Dipeptidase A - chemistry ; Peptidyl-Dipeptidase A - metabolism ; Protein Domains ; Proteins ; protein–protein complex ; Receptors, Virus ; Respiratory diseases ; SARS Virus - chemistry ; SARS Virus - metabolism ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Simulation ; Spike Glycoprotein, Coronavirus - chemistry ; Spike Glycoprotein, Coronavirus - metabolism ; Spike protein ; Viruses ; virus–host interactions</subject><ispartof>Viruses, 2020-04, Vol.12 (5), p.497</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983</citedby><cites>FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983</cites><orcidid>0000-0003-0480-0438 ; 0000-0002-9357-4526</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2398025812/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2398025812?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768,74382,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32365751$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brielle, Esther S</creatorcontrib><creatorcontrib>Schneidman-Duhovny, Dina</creatorcontrib><creatorcontrib>Linial, Michal</creatorcontrib><title>The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor</title><title>Viruses</title><addtitle>Viruses</addtitle><description>The COVID-19 disease has plagued over 200 countries with over three million cases and has resulted in over 200,000 deaths within 3 months. To gain insight into the high infection rate of the SARS-CoV-2 virus, we compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations. SARS-CoV, SARS-CoV-2, and HCoV-NL63 recognize ACE2 as the natural receptor but present a distinct binding interface to ACE2 and a different network of residue-residue contacts. SARS-CoV and SARS-CoV-2 have comparable binding affinities achieved by balancing energetics and dynamics. The SARS-CoV-2-ACE2 complex contains a higher number of contacts, a larger interface area, and decreased interface residue fluctuations relative to the SARS-CoV-ACE2 complex. These findings expose an exceptional evolutionary exploration exerted by coronaviruses toward host recognition. We postulate that the versatility of cell receptor binding strategies has immediate implications for therapeutic strategies.</description><subject>ACE2</subject><subject>Angiotensin-Converting Enzyme 2</subject><subject>Atoms &amp; subatomic particles</subject><subject>Betacoronavirus - chemistry</subject><subject>Betacoronavirus - metabolism</subject><subject>Binding sites</subject><subject>Coronaviridae</subject><subject>coronavirus evolution</subject><subject>Coronavirus NL63, Human - chemistry</subject><subject>Coronavirus NL63, Human - metabolism</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Exploration</subject><subject>Humans</subject><subject>Interfaces</subject><subject>Middle East respiratory syndrome</subject><subject>molecular dynamics</subject><subject>Molecular Dynamics Simulation</subject><subject>Peptidyl-Dipeptidase A - chemistry</subject><subject>Peptidyl-Dipeptidase A - metabolism</subject><subject>Protein Domains</subject><subject>Proteins</subject><subject>protein–protein complex</subject><subject>Receptors, Virus</subject><subject>Respiratory diseases</subject><subject>SARS Virus - chemistry</subject><subject>SARS Virus - metabolism</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Simulation</subject><subject>Spike Glycoprotein, Coronavirus - chemistry</subject><subject>Spike Glycoprotein, Coronavirus - metabolism</subject><subject>Spike protein</subject><subject>Viruses</subject><subject>virus–host interactions</subject><issn>1999-4915</issn><issn>1999-4915</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1vEzEQhi0EoqVw4A8gS1zgsODPXc8FKQqBRqqE1BYkTpbX600cbdap7Q3032OaErWcPPI8ejQzL0KvKfnAOZCPe8qIJAKaJ-iUAkAlgMqnD-oT9CKlDSF1DaR5jk4447VsJD1FP6_XDl_NLq-qefhRMbz47WJO2ODPPmU_2uz3pZ-jyW51i_sQ8XLMLprSGFf4l89rnIthNl8wfD5tzYgvnXW7HOJL9Kw3Q3Kv7t8z9P3L4np-Xl18-7qczy4qK2rIlRKdkq1yyjLLW9ZKUMw1itbC9haoAku56CnUktNWkoZ3ljFDWqMo6zpQ_AwtD94umI3eRb818VYH4_XdR4grbWL2dnDattZIC9YVn-gkVwC1oG1jW-gMGFNcnw6u3dRuXWfdWDYfHkkfd0a_1quw1w0DSiQvgnf3ghhuJpey3vpk3TCY0YUpacZB1aJcnxb07X_oJkxxLKe6owiTZcNCvT9QNoaUouuPw1Ci_4avj-EX9s3D6Y_kv7T5H_sQp-c</recordid><startdate>20200430</startdate><enddate>20200430</enddate><creator>Brielle, Esther S</creator><creator>Schneidman-Duhovny, Dina</creator><creator>Linial, Michal</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0480-0438</orcidid><orcidid>https://orcid.org/0000-0002-9357-4526</orcidid></search><sort><creationdate>20200430</creationdate><title>The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor</title><author>Brielle, Esther S ; Schneidman-Duhovny, Dina ; Linial, Michal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>ACE2</topic><topic>Angiotensin-Converting Enzyme 2</topic><topic>Atoms &amp; subatomic particles</topic><topic>Betacoronavirus - chemistry</topic><topic>Betacoronavirus - metabolism</topic><topic>Binding sites</topic><topic>Coronaviridae</topic><topic>coronavirus evolution</topic><topic>Coronavirus NL63, Human - chemistry</topic><topic>Coronavirus NL63, Human - metabolism</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Exploration</topic><topic>Humans</topic><topic>Interfaces</topic><topic>Middle East respiratory syndrome</topic><topic>molecular dynamics</topic><topic>Molecular Dynamics Simulation</topic><topic>Peptidyl-Dipeptidase A - chemistry</topic><topic>Peptidyl-Dipeptidase A - metabolism</topic><topic>Protein Domains</topic><topic>Proteins</topic><topic>protein–protein complex</topic><topic>Receptors, Virus</topic><topic>Respiratory diseases</topic><topic>SARS Virus - chemistry</topic><topic>SARS Virus - metabolism</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Simulation</topic><topic>Spike Glycoprotein, Coronavirus - chemistry</topic><topic>Spike Glycoprotein, Coronavirus - metabolism</topic><topic>Spike protein</topic><topic>Viruses</topic><topic>virus–host interactions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brielle, Esther S</creatorcontrib><creatorcontrib>Schneidman-Duhovny, Dina</creatorcontrib><creatorcontrib>Linial, Michal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Viruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brielle, Esther S</au><au>Schneidman-Duhovny, Dina</au><au>Linial, Michal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor</atitle><jtitle>Viruses</jtitle><addtitle>Viruses</addtitle><date>2020-04-30</date><risdate>2020</risdate><volume>12</volume><issue>5</issue><spage>497</spage><pages>497-</pages><issn>1999-4915</issn><eissn>1999-4915</eissn><abstract>The COVID-19 disease has plagued over 200 countries with over three million cases and has resulted in over 200,000 deaths within 3 months. To gain insight into the high infection rate of the SARS-CoV-2 virus, we compare the interaction between the human ACE2 receptor and the SARS-CoV-2 spike protein with that of other pathogenic coronaviruses using molecular dynamics simulations. SARS-CoV, SARS-CoV-2, and HCoV-NL63 recognize ACE2 as the natural receptor but present a distinct binding interface to ACE2 and a different network of residue-residue contacts. SARS-CoV and SARS-CoV-2 have comparable binding affinities achieved by balancing energetics and dynamics. The SARS-CoV-2-ACE2 complex contains a higher number of contacts, a larger interface area, and decreased interface residue fluctuations relative to the SARS-CoV-ACE2 complex. These findings expose an exceptional evolutionary exploration exerted by coronaviruses toward host recognition. We postulate that the versatility of cell receptor binding strategies has immediate implications for therapeutic strategies.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32365751</pmid><doi>10.3390/v12050497</doi><orcidid>https://orcid.org/0000-0003-0480-0438</orcidid><orcidid>https://orcid.org/0000-0002-9357-4526</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1999-4915
ispartof Viruses, 2020-04, Vol.12 (5), p.497
issn 1999-4915
1999-4915
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_cbca5c9cef194d53899641b7cb9da9aa
source PubMed (Medline); Publicly Available Content Database; Coronavirus Research Database
subjects ACE2
Angiotensin-Converting Enzyme 2
Atoms & subatomic particles
Betacoronavirus - chemistry
Betacoronavirus - metabolism
Binding sites
Coronaviridae
coronavirus evolution
Coronavirus NL63, Human - chemistry
Coronavirus NL63, Human - metabolism
Coronaviruses
COVID-19
Disease transmission
Epidemics
Exploration
Humans
Interfaces
Middle East respiratory syndrome
molecular dynamics
Molecular Dynamics Simulation
Peptidyl-Dipeptidase A - chemistry
Peptidyl-Dipeptidase A - metabolism
Protein Domains
Proteins
protein–protein complex
Receptors, Virus
Respiratory diseases
SARS Virus - chemistry
SARS Virus - metabolism
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Simulation
Spike Glycoprotein, Coronavirus - chemistry
Spike Glycoprotein, Coronavirus - metabolism
Spike protein
Viruses
virus–host interactions
title The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T23%3A35%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20SARS-CoV-2%20Exerts%20a%20Distinctive%20Strategy%20for%20Interacting%20with%20the%20ACE2%20Human%20Receptor&rft.jtitle=Viruses&rft.au=Brielle,%20Esther%20S&rft.date=2020-04-30&rft.volume=12&rft.issue=5&rft.spage=497&rft.pages=497-&rft.issn=1999-4915&rft.eissn=1999-4915&rft_id=info:doi/10.3390/v12050497&rft_dat=%3Cproquest_doaj_%3E2398025812%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c469t-84d85b8e8c2c3b2b5982e78164cfc9189c134f196531b5073dc22a0ba812dd983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2398025812&rft_id=info:pmid/32365751&rfr_iscdi=true